{{Rsnum
|rsid=585344
|Chromosome=18
|position=50872497
|Orientation=minus
|GMAF=0.3186
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 35.4 | 50.8 | 13.8
| HCB | 44.4 | 42.2 | 13.3
| JPT | 36.4 | 45.5 | 18.2
| YRI | 66.7 | 28.6 | 4.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 44.4 | 42.2 | 13.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{omim
|id=154270
|desc=MALIC ENZYME 2; ME2
|rsnum=585344
}}

{{omim
|id=154270
|rsnum=585344
|variant=0001
}}

{{PMID|15532013|OA=1
}} Malic enzyme 2 may underlie susceptibility to adolescent-onset idiopathic generalized epilepsy.

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}